Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$793
|
$747B |
14.1x |
35.0x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$192
|
$405B |
6.9x |
15.3x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$157
|
$391B |
4.3x |
11.9x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 439
|
$320B |
6.5x |
13.0x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 259
|
$283B |
3.6x |
9.2x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 96
|
$263B |
4.7x |
11.5x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£105
|
$247B |
4.2x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$83
|
$235B |
3.6x |
8.4x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$295
|
$207B |
6.0x |
11.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$190B |
3.0x |
7.8x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$110
|
$153B |
5.3x |
12.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$135B |
2.9x |
10.6x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$134B |
2.5x |
8.5x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$469
|
$116B |
10.1x |
35.2x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$96.7B |
2.2x |
6.5x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 241
|
$86.9B |
5.6x |
16.7x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4378
|
$76.3B |
2.4x |
9.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$74.0B |
7.9x |
18.3x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6837
|
$71.3B |
8.6x |
17.3x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€27
|
$70.1B |
1.3x |
6.1x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€113
|
$66.1B |
2.6x |
9.2x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 564
|
$54.1B |
6.0x |
21.1x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 57
|
$49.7B |
11.8x |
43.9x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1672
|
$44.1B |
7.0x |
24.7x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3258
|
$37.7B |
2.8x |
13.6x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 55
|
$34.0B |
1.9x |
6.7x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 178600
|
$30.6B |
10.5x |
33.9x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 45
|
$27.9B |
2.5x |
12.1x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$24.2B |
1.7x |
5.6x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$134
|
$23.7B |
2.5x |
7.4x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6690
|
$23.2B |
1.4x |
6.3x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$22.9B |
2.3x |
6.5x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1407
|
$21.7B |
1.6x |
8.6x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$20.9B |
7.2x |
7.8x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 31
|
$20.6B |
11.5x |
30.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$19.1B |
2.2x |
8.9x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 439000
|
$16.9B |
134.5x |
317.4x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 81
|
$16.8B |
11.3x |
265.3x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 281
|
$15.6B |
29.1x |
67.2x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€54
|
$15.6B |
5.3x |
14.3x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3314
|
$13.4B |
9.6x |
29.5x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2578
|
$13.1B |
8.7x |
34.2x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 6
|
$12.8B |
3.0x |
13.2x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1485
|
$12.8B |
3.9x |
15.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$12.7B |
5.0x |
21.0x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 113
|
$12.5B |
30.8x |
-2373.3x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.1B |
2.1x |
14.9x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1254
|
$12.1B |
3.1x |
11.7x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 286
|
$11.6B |
4.1x |
11.2x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 24
|
$11.6B |
2.0x |
12.4x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€67
|
$11.1B |
5.9x |
18.5x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$11.0B |
1.7x |
5.6x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 980
|
$10.9B |
3.9x |
13.5x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.5B |
2.6x |
10.4x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2480
|
$10.3B |
3.3x |
8.1x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1378
|
$10.3B |
2.9x |
8.3x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1893
|
$10.2B |
3.7x |
15.6x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€106
|
$10.0B |
2.4x |
6.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 340
|
$9.7B |
35.4x |
-220.3x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 40
|
$9.7B |
1.6x |
12.5x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 22
|
$9.4B |
2.9x |
7.3x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 34410
|
$8.2B |
10.8x |
39.9x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$57
|
$7.8B |
6.9x |
10.8x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$7.6B |
0.2x |
3.5x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1125
|
$7.6B |
2.0x |
9.6x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2480
|
$7.5B |
2.2x |
9.6x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 374
|
$7.4B |
4.0x |
18.9x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2182
|
$7.3B |
4.5x |
25.0x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 34
|
$7.3B |
N/A |
N/A |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3996
|
$7.3B |
1.3x |
10.8x |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 25
|
$7.2B |
4.3x |
8.9x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€136
|
$7.2B |
N/A |
N/A |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£20
|
$7.0B |
2.1x |
7.9x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 174
|
$6.7B |
15.1x |
20.7x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 46
|
$6.5B |
9.6x |
33.7x |
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 48
|
$6.5B |
N/A |
N/A |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 31
|
$6.5B |
1.5x |
8.1x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 4807
|
$6.3B |
4.1x |
20.9x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€198
|
$6.3B |
2.7x |
10.0x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3242
|
$6.1B |
13.6x |
43.1x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 111496
|
$6.1B |
3.9x |
56.6x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.9B |
5.0x |
16.3x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 318
|
$5.4B |
N/A |
N/A |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 536
|
$5.4B |
12.1x |
38.8x |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 57
|
$5.3B |
6.6x |
22.8x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 102
|
$5.2B |
2.7x |
11.0x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 68
|
$5.2B |
17.9x |
-47.4x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$5.1B |
1.8x |
7.9x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 20
|
$5.1B |
5.7x |
13.3x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10200
|
$5.0B |
1.9x |
5.0x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 74
|
$4.9B |
12.9x |
76.5x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1612
|
$4.8B |
1.4x |
6.3x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$4.7B |
14.6x |
-49.1x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 116
|
$4.6B |
1.9x |
8.1x |
Hypera
|
Brazil |
Biopharmaceuticals,
Drug Development & Therapeutics
|
BRL 27
|
$4.5B |
3.1x |
11.4x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$19
|
$4.4B |
9.5x |
21.8x |
Gan & Lee Pharmaceuticals
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 56
|
$4.4B |
8.4x |
29.8x |
Kalbe Farma
|
Indonesia |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
IDR 1595
|
$4.4B |
2.1x |
13.9x |
Zelgen Biopharmaceuticals
|
China |
Drug Development & Therapeutics,
Biopharmaceuticals
|
CNY 120
|
$4.3B |
44.2x |
-5871.6x |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 76
|
$4.2B |
10.7x |
28.4x |